We are live on ! Find out more
PETX

Aratana Therapeutics
PETX

Delisted

PETX was delisted on the 17th of July, 2019.

13 hedge funds and large institutions have $37.8M invested in Aratana Therapeutics in 2013 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

22.81% more ownership

Funds ownership: 0% → 22.81% (+23%)

Holders
13
Holders Change
+13
Holders Change %
–
% of All Funds
0.42%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

PETX Hedge Fund Activity: Q2 2013 in Review

13 of the 3,075 institutional investors tracked by Wall St. Rank reported a position in Aratana Therapeutics (PETX) for Q2 2013, worth a combined $37.8M.

Fund positioning in PETX was balanced in Q2 2013: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 13 institutional investors held Aratana Therapeutics (PETX) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $37.8M of Aratana Therapeutics stock for Q2 2013.
  • 0 funds opened new Aratana Therapeutics positions in Q2 2013 and 0 closed out.

Based on aggregated 13F filings for Q2 2013.